ENTRY       D11996                      Drug
NAME        Feladilimab (USAN/INN);
            Feladilimab (genetical recombination) (JAN)
FORMULA     C6450H9888N1696O2036S46
EXACT_MASS  145150.9489
MOL_WEIGHT  145240.6573
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGSSVKV SCKASGYTFT DYAMHWVRQA PGQGLEWMGL ISIYSDHTNY
            NQKFQGRVTI TADKSTSTAY MELSSLRSED TAVYYCGRNN YGNYGWYFDV WGQGTTVTVS
            SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTK TYTCNVDHKP SNTKVDKRVE SKYGPPCPPC PAPEFEGGPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSQE DPEVQFNWYV DGVEVHNAKT KPREEQFNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKGLP SSIEKTISKA KGQPREPQVY TLPPSQEEMT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSR LTVDKSRWQE
            GNVFSCSVMH EALHNHYTQK SLSLSLGK
            (Light chain)
            EIVLTQSPAT LSLSPGERAT LSCSASSSVS YMHWYQQKPG QAPRLLIYDT SKLASGIPAR
            FSGSGSGTDY TLTISSLEPE DFAVYYCFQG SGYPYTFGQG TKLEIKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
            (Disulfide bridge: H22-H96, H135-L213, H148-H204, H227-H'227, H230-H'230, H262-H322, H368-H426, H'22-H'26, H'135-L'213, H'148-H'204, H'262-H'322, H'368-H'426, L23-L87, L133-L193, L'23-L'87, L'133-L'193)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
COMMENT     Treatment of advanced solid tumors
TARGET      ICOS (CD278) [HSA:29851] [KO:K06713]
  PATHWAY   hsa04514(29851)  Cell adhesion molecules
            hsa04660(29851)  T cell receptor signaling pathway
            hsa04672(29851)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                ICOS (CD278)
                 D11996  Feladilimab (USAN/INN)
DBLINKS     CAS: 2252518-85-5
///
